FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease.
Andras BikovPeter LangeJulie A AndersonRobert D BrookPeter M A CalverleyBartolome R CelliNicholas J CowansCourtney CrimIan J DixonFernando J MartinezDavid E NewbyJulie C YatesJorgen VestboPublished in: International journal of chronic obstructive pulmonary disease (2020)
Our results suggest that FEV1 is a stronger predictor for all-cause mortality than FVC in moderate COPD patients with heightened cardiovascular risk and that subjects with moderate COPD have very different risks.